Viemed’s efforts pay off, with revenues increasing 28%
By HME News Staff
Updated 9:46 AM CDT, Wed May 6, 2026
LAFAYETTE, La. – Viemed Healthcare reported net revenues of $75.4 million for the first quarter ended March 31, 2026, an increase of $16.3 million, or 28%, over the comparable quarter in 2025.
Net income attributable to Viemed totaled $2.6 million, or $0.06 per diluted share. Adjusted EBITDA was $14.3 million, a 12% increase.
“The first quarter showed clearly that the work we have put into diversifying and scaling this platform is paying off,” said Casey Hoyt, CEO. “Sleep and maternal health are growing rapidly, our ventilator business is showing the momentum we have been working toward, and the combination of strong revenue growth and a more capital-efficient business mix is producing free cash flow results that look fundamentally different than they did a year ago. We believe that trajectory will become an increasingly important part of how investors understand and value Viemed. We are executing the plan we communicated, the forward indicators across the business are pointing in the right direction, and we enter the second quarter with real confidence in where this year is headed."
Viemed is providing the following financial guidance for the year ending Dec. 31, 2026:
- Net revenue in the range of $312 million to $320 million.
- Adjusted EBITDA in the range of $65 million to $69 million.
- Net capital expenditures in the range of 9% to 10.5%.
Comments